Journal ArticleOPEN ACCESS

Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1

Clinical Case Reports (2020) 8(11) 2125-2128
DOI: 10.1002/ccr3.3071
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c-NFs) and promote growth of pre-existing c-NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.

Author supplied keywords

Cite

CITATION STYLE

APA

Yasuda, K. ichi, Nobeyama, Y., Ishiji, T., Ota, A., & Asahina, A. (2020). Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1. Clinical Case Reports, 8(11), 2125–2128. https://doi.org/10.1002/ccr3.3071

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free